Crystal violet structural analogues identified by in silico drug repositioning present anti-Trypanosoma cruzi activity through inhibition of proline transporter TcAAAP069.

• Hauptverfasser: Melisa Sayé (Verfasst von), Lucrecia Gauna (Verfasst von), Edward Valera-Vera (Verfasst von), Chantal Reigada (Verfasst von), Mariana R Miranda (Verfasst von), Claudio A Pereira (Verfasst von)
• Format: Buch
• Veröffentlicht: Public Library of Science (PLoS), 2020-01-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

<h4>Background</h4>Crystal violet (CV) was used for several years in blood banks to eliminate the parasite Trypanosoma cruzi in endemic areas in order to prevent transfusion-transmitted Chagas disease. One mechanism of action described for CV involves inhibition of proline uptake. In T....